近期论文
查看导师新发文章
（温馨提示：请注意重名现象，建议点开原文通过作者单位确认）
1.HeD†,ZhuQ†,ZhouQ,QiQ,SunH,ZachariahLM,WangG,ReveilleJD,GuanY,ZhouX.ClinRheumatol.CorrelationofserumMMP3andotherbiomarkerswithclinicaloutcomesinpatientswithankylosingspondylitis:apilotstudy.ClinRheumatol.2017Apr22.IF:2.042
2.HeD,LiuJ,HaiY,ZhuQ,ShenY,GuoS,ZhangW,ZhouX.IncreasedDOT1LinsynovialbiopsiesofpatientswithOAandRA.ClinRheumatol.Publishedonline:13Dec2017https://doi.org/10.1007/s10067-017-3941-x.IF:2.365
3.HeD†,WangJ†YiL,GuoX,GuoS,GuoG,TuW,WuW,YangL,XiaoR,LiY,ChuH,JinL,ZouH,ReveilleJD,AssassiS,MayesMD,ZhouX*.AssociationoftheHLA-DRB1withsclerodermainChinesepopulation.PLoSOne.2014;9(1):e87363.IF:3.234;TimesCited:4
4.HeD*,BaiF,ZhangS,JiangT,ShenJ,ZhuQ,YueT,ShaoL,GaoY,FengY,WengX,ZouH,ZhangY,ZhangW*.Highincidenceoftuberculosisinfectioninrheumaticdiseasesandimpactforchemoprophylacticpreventionoftuberculosisactivationduringbiologicstherapy.ClinVaccineImmunol.2013;20(6):842-7.IF:2.47
5.HeDY,DaiSM*.Anti-inflammatoryandimmunomodulatoryeffectsofpaeonialactiflorapall.,atraditionalchineseherbalmedicine.FrontPharmacol.2011;2:10.IF:3.802
6.FanLY†*,HeDY†,WangQ†,ZongM,ZhangH,YangL,SunLS.Citrullinatedvimentinstimulatesproliferation,pro-inflammatorycytokinesecretion,andPADI4andRANKLexpressionoffibroblast-likesynoviocytesinrheumatoidarthritis.ScandJRheumatol.2012;41(5):354-8.IF:2.527
7.NiuX†*,HeD†*,DengS,LiW,XiY,XieC,JiangT,ZhangJZ,DongC,ChenG*.RegulatoryimmuneresponsesinducedbyIL-1receptorantagonistinrheumatoidarthritis.MolImmunol.2011;49(1-2):290-6.IF:2.973
8.NiuX,HeD,ZhangX,YueT,LiN,ZhangJZ,DongC,ChenG.IL-21regulatesTh17cellsinrheumatoidarthritis.HumImmunol.2010;71(4):334-41.IF:2.872;TimesCited:86
9.SongJ,LiuH,ZhuQ,MiaoY,WangF,YangF,ChengW,XiY,NiuX,HeD*,ChenG*.T-614PromotesOsteoblasticCellDifferentiationbyIncreasingDlx5ExpressionandRegulatingtheActivationofp38andNF-κB.BioMedResearchInternational.Volume2018,ArticleID4901591,8pages.https://doi.org/10.1155/2018/4901591.IF:2.476
10.GuoS,WangR,JiangT,BaiF,DingQ,MaY,WangY,YangY,WangX,TangL,NieH,WangJ,HeD.Alterationsanddiagnosispotentialofserumlipidprofilesinrheumatoidarthritispatints.IntJClinExpPathol,2017,10(3):3503-3509.IF:1.581
11.GuoS,JiangT,WangR,ShenY,ZhuX,BF,DingQ,ChenG*,HeD*.Genome-wideDNAmethylationpatternsinCD4+TrevealsignificantcontributionofDNAmethylationtorheumatoidarthritis.ModRheumatol,2016;EarlyOnline:1–7.IF:1.843;
12.ShenY†,JiangT†,WangR,HeS,GuoM,ZuoJ*,HeD*.(5R)-5-Hydroxytriptolide(LLDT-8)inhibitsosteoclastogenesisviaRANKL/RANK/OPGsignalingpathway.BMCComplementAlternMed.2015Mar24;15:77.IF:2.02;TimesCited:1
13.XuY†,ZhuQ†,SongJ,LiuH,MiaoY,YangF,WangF,ChengW,XiY,NiuX,HeD*,ChenG*.Regulatoryeffectofiguratimodonthebalanceofthsubsetsandinhibitionofinflammatorycytokinesinpatientswithrheumatoidarthritis.MediatorsInflamm.2015;2015:356040.IF:3.236;
14.ZhangW†,CongXL†,QinYH,HeZW,HeDY*,DaiSM*.IL-18upregulatestheproductionofkeyregulatorsofosteoclastogenesisfromfibroblast-likesynoviocytesinrheumatoidarthritis.Inflammation.2013;36(1):103-9.IF:2.208
15.XieWL,LiZL,XuZ,QuHR,XueL,SuX,WeiQH,WangH,LiMY,ZhaoFT,JiangLD,ZhangJ,WanWG,DaiM,YangCD,GuanJL*,SuL,ZhaoDB,HeDY*,XuHJ,ZouHJ,BaoCD.Theriskfactorsfornosocomialinfectioninchinesepatientswithactiverheumatoidarthritisinshanghai.ISRNRheumatol.2012;2012:215692.IF:4.475
16.NieH†,ZhengY†,LiR†,GuoTB,HeD,FangL,LiuX,XiaoL,ChenX,WanB,ChinYE,ZhangJZ*.PhosphorylationofFOXP3controlsregulatoryTcellfunctionandisinhibitedbyTNF-αinrheumatoidarthritis.NatMed.2013;9(3):322-8.IF:28.054;TimesCited:158
17.ZhuS†,PanW†,SongX,LiuY,ShaoX,TangY,LiangD,HeD,WangH,LiuW,ShiY,HarleyJB,ShenN*,QianY*.ThemicroRNAmiR-23bsuppressesIL-17-associatedautoimmuneinflammationbytargetingTAB2,TAB3andIKK-α.NatMed.2012;18(7):1077-86.IF:22.864;TimesCited:169
18.FanL†*,ZongM†,GongR,HeD,LiN,SunLS,YeQ,YuS.PADI4EpigeneticallySuppressesp21TranscriptionandInhibitsCellApoptosisinFibroblast-likeSynoviocytesfromRheumatoidArthritisPatients.Int.J.Biol.Sci.2017,13(3):358-366.IF:3.982
19.WangG,BiZL,Lix,Z,ZhaoD,ChenJ,HeD,WangCN,DuenasH,SkljarevskiV,YueL*.EfficacyandsafetyofduloxetineinChinesepatientswithchronicpainduetoosteoarthritis:arandomized,double-blind,placebo-controlledstudy.OsteoarthritisandCartilage.(2017)1-7.IF:4.472
20.ShiC†,LiH†,CouturierJP,YangK,GuoX,HeD,LewisDE,ZhouX*.AllelespecificexpressionofMICAvariantsinhumanfibroblastssuggestsapathogenicmechanism.OpenRheumatolJ.2015Aug26;9:60-4.TimesCited:1
21.WeiL,ZhangC,ChenHY,ZhangZJ,JiZF,YueT,DaiXM,ZhuQ,MaLL,HeDY,JiangLD*.DopaminereceptorDR2expressioninBcellsisnegativelycorrelatedwithdiseaseactivityinrheumatoidarthritispatients.Immunobiology.2015Mar;220(3):323-30.IF:3.044
22.JiangL†,YinJ†,YeL†,YangJ†,HemaniG,LiuAJ,ZouH,HeD,SunL,ZengX,LiZ,ZhengY,etal.Novelrisklociforrheumatoidarthritisinhanchineseandcongruencewithriskvariantsineuropeans.ArthritisRheum.2014.IF:7.871;TimesCited:21
23.ZhengY,SunL,JiangT,ZhangD,HeD,NieH.TNFαpromotesTh17celldifferentiationthroughIL-6andIL-1βproducedbymonocytesinrheumatoidarthritis.JournalofImmunologyResearch,Volume2014,ArticleID385352,12pages.IF:3.064;TimesCited:5
24.GuiH†,LiuX†,WangZW,HeDY,SuDF,DaiSM*.Expressionofcannabinoidreceptor2anditsinhibitoryeffectsonsynovialfibroblastsinrheumatoidarthritis.Rheumatology(Oxford).2014;53(5):802-9.IF:4.475
25.WangJ,YiL,GuoX,HeD,LiH,GuoG,WangY,ZouH,GuY,TuW,WuW,YangL,XiaoR,LaiS,AssassiS,MayesMD,ZhouX.LackofassociationoftheCD247SNPrs2056626withsystemicsclerosisinHanChinese.OpenRheumatolJ.2014Oct2;8:43-5.TimesCited:5
26.ZhangX,ZhangF,WuD,BaoC,ZhuP,ZhangX,HuangC,HeD,TaoY,FangY,GuJ,WuH,SunL,YangX,HuangF,XuH,ZhaoD,ZhangM,ZhengY,LiZ*.SafetyofinfliximabtherapyinrheumatoidarthritispatientswithpreviousexposuretohepatitisBvirus.IntJRheumDis.2013;16(4):408-12.IF:1.771;TimesCited:4
27.FanL*†,WangQ†,LiuR†,ZongM,HeD,ZhangH,DingY,MaJ.Citrullinatedfibronectininhibitsapoptosisandpromotesthesecretionofpro-inflammatorycytokinesinfibroblast-likesynoviocytesinrheumatoidarthritis.ArthritisResTher.2012;14(6):R266.IF:4.302;TimesCited:17
28.LiY,JiangL,ZhangS,YinL,MaL,HeD,ShenJ.MethotrexateattenuatestheTh17/IL-17levelsinperipheralbloodmononuclearcellsfromhealthyindividualsandRApatients.RheumatolInt.2012Aug;32(8):2415-22.IF:2.214;TimesCited:26
29.HuC,QianL,MiaoY,HuangQ,MiaoP,WangP,YuQ,NieH,ZhangJ,HeD,XuR,ChenX,LiuB,ZhangD.Antigen-presentingeffectsofeffectormemoryVγ9Vδ2Tcellsinrheumatoidarthritis.CellMolImmunol.2012May;9(3):245-54.IF:3.419;TimesCited:28
30.MaX,HeL,HeD,XuJ*.Chloroquinekeratopathyofrheumatoidarthritispatientsdetectedbyinvivoconfocalmicroscopy.CurrEyeRes.2012;37(4):293-9.IF:1.71;TimesCited:6
近5年发表的重要中文论文：
1.何东仪.雷公藤—抗风湿新策略.中华风湿病学杂志.2018,22(3):1-3.
2.何东仪.秦亮甫教授辨治痛风经验撷英.上海中医药大学学报,2011,25(6):1-2.
3.何东仪,程鹏,李姝玉,李卓伶白凤敏,沈杰,丁琴,连艳玲,徐列明,聂红.突变型瓜氨酸波形蛋白抗体在类风湿关节炎诊断中的意义.现代免疫学,2010,30(4):318-313.
4.何东仪，聂红，王岩，章晓芳，郑配国，徐列明.（-）-表没食子儿茶素没食子酸酯对胶原诱导性关节炎小鼠免疫调节机制研究.中华风湿病学杂志.2009,13(8):538-541.
5.何东仪,钟丽民,沈杰,程鹏,李卓伶,姜婷.葡萄糖6-磷酸异构酶检测在类风湿关节炎中的意义.现代免疫学.2008,28(4):326-330.
6.何东仪,冯伟,姜婷,朱雅萍,张凤华,周琦.问荆合剂对胶原诱导关节炎大鼠滑膜细胞分泌TNF-α、IL-β水平的影响.现代免疫学.2006,26(1):69-71.
7.刘佳，童萍，何东仪*.新雷公藤衍生物雷藤舒对类风湿关节炎滑膜细胞基因表达的影响.上海中医药大学学报.2017,31(6):70-75.
8.汪荣盛,刘佳,童萍,何世君,吴言为,左建平,何东仪*.雷藤舒对TNF-α诱导的人类风湿关节炎滑膜成纤维细胞促凋亡、抗炎及对Ras-MAPKs信号通路的调节作用.上海中医药大学学报,2016,30(3):82-87.
9.汪荣盛,何东仪*.何东仪辨治类风湿关节炎继发骨质疏松症的经验.中医文献杂志,2016,3:47-50.
10.童萍,刘佳,何东仪*.雷藤舒（LLDT-8）对成纤维样滑膜细胞分泌趋化因子的影响.现代免疫学,2016,36(6):448-454.
11.郭梦如，何东仪*，姚广涛，秦亮甫，李鹤，符胜光，陈华英，甄滢滢.消痹膏镇痛抗炎作用的实验研究.上海中医药大学学报,2014,28(2):56-59.
12.姜婷，程鹏，秦亮甫，丁琴，何东仪*，郭梦如，劳志英，马艳平.秦氏消痹膏外敷结合西药治疗湿热痹阻型类风湿关节炎70例.上海中医药杂志,2014,48(4):67-70.
13.缪瑾，何东仪*.226例类风湿关节炎患者医院感染临床分析与预防对策.中华医院感染学杂志.2013,23(4):803-805.
14.连艳玲，何东仪*，聂红，冯伟，左建平.雷藤舒在类风湿关节炎中免疫调节机制的研究。现代免医学.2012.32(３):239-243.
15.李卓伶，汪荣盛，沈杰，徐列明，岳涛，朱琦，姜婷，何东仪*.补肾化瘀法对早期类风湿关节炎患者骨代谢的影响.中医杂志.2012,53(3):215-218.
16.朱琦，姜婷，周嘉陵，李姝玉，何东仪*.不同治疗方案对类风湿关节炎患者关节放射学评分骨密度及血清骨代谢标志物影响的研究.中国药物与临床.2012,12(10):1264-1269.
17.程鹏，钟丽民，沈杰，李卓伶，姜婷，何东仪*.抗突变型瓜氨酸波形蛋白检测在类风湿关节炎中的意义.中国免疫学杂志.2008,24:1028-1032.
18.朱琦,宋经略,徐云芝,刘弘励,苗雨桐,杨帆,王飞燕,陈广洁,何东仪,钮晓音.艾拉莫德对类风湿关节炎临床疗效及T辅助细胞亚群调节作用的研究[J].中华风湿病学杂志,2016,(2):93-99.
19.李振彬，辛立波，徐铮，齐静，何东仪，杨静.雷公藤多苷对rmMIF诱导大鼠成纤维样滑膜细胞增殖及RANKL/OPG表达的影响.解放军医药杂志.2013,25(4):10-14.
著作
《秦亮甫临床治病录》，排名1（主编），科学出版社，中国上海，2017年
《风湿免疫性疾病诊疗标准》，排名2（副主编），上海科学普及出版社，中国上海，2015年
《秦亮甫临证思辨与医案集萃》，主编，科学技术出版社2019年
京公网安备 11010802027423号